Project
GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for EPAS1_BCL3
Z-value: 2.94
Motif logo
Transcription factors associated with EPAS1_BCL3
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
EPAS1
|
ENSG00000116016.9 | endothelial PAS domain protein 1 |
|
BCL3
|
ENSG00000069399.8 | BCL3 transcription coactivator |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| EPAS1 | hg19_v2_chr2_+_46524537_46524553 | 0.55 | 9.6e-19 | Click! |
| BCL3 | hg19_v2_chr19_+_45251804_45251840 | -0.22 | 8.7e-04 | Click! |
Activity profile of EPAS1_BCL3 motif
Sorted Z-values of EPAS1_BCL3 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr19_+_35629702 | 124.39 |
ENST00000351325.4
|
FXYD1
|
FXYD domain containing ion transport regulator 1 |
| chr15_-_60690932 | 71.07 |
ENST00000559818.1
|
ANXA2
|
annexin A2 |
| chr20_+_10199468 | 57.06 |
ENST00000254976.2
ENST00000304886.2 |
SNAP25
|
synaptosomal-associated protein, 25kDa |
| chr16_-_70719925 | 54.56 |
ENST00000338779.6
|
MTSS1L
|
metastasis suppressor 1-like |
| chr3_-_58572760 | 51.71 |
ENST00000447756.2
|
FAM107A
|
family with sequence similarity 107, member A |
| chr1_+_6845384 | 45.50 |
ENST00000303635.7
|
CAMTA1
|
calmodulin binding transcription activator 1 |
| chr6_+_31620191 | 44.56 |
ENST00000375918.2
ENST00000375920.4 |
APOM
|
apolipoprotein M |
| chr8_+_21915368 | 43.97 |
ENST00000265800.5
ENST00000517418.1 |
DMTN
|
dematin actin binding protein |
| chr19_+_56915668 | 42.39 |
ENST00000333201.9
ENST00000391778.3 |
ZNF583
|
zinc finger protein 583 |
| chr4_-_5894777 | 37.87 |
ENST00000324989.7
|
CRMP1
|
collapsin response mediator protein 1 |
| chr8_-_134309335 | 37.07 |
ENST00000522890.1
ENST00000323851.7 ENST00000518176.1 ENST00000354944.5 ENST00000537882.1 ENST00000522476.1 ENST00000518066.1 ENST00000521544.1 ENST00000518480.1 ENST00000523892.1 |
NDRG1
|
N-myc downstream regulated 1 |
| chr2_+_20646824 | 36.93 |
ENST00000272233.4
|
RHOB
|
ras homolog family member B |
| chr8_-_27462822 | 36.61 |
ENST00000522098.1
|
CLU
|
clusterin |
| chr16_+_6069072 | 36.17 |
ENST00000547605.1
ENST00000550418.1 ENST00000553186.1 |
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
| chr4_+_158141806 | 36.10 |
ENST00000393815.2
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
| chr2_+_203499901 | 35.45 |
ENST00000303116.6
ENST00000392238.2 |
FAM117B
|
family with sequence similarity 117, member B |
| chr19_+_35630022 | 35.33 |
ENST00000589209.1
|
FXYD1
|
FXYD domain containing ion transport regulator 1 |
| chr7_+_154002189 | 32.48 |
ENST00000332007.3
|
DPP6
|
dipeptidyl-peptidase 6 |
| chr16_+_22825475 | 32.33 |
ENST00000261374.3
|
HS3ST2
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 2 |
| chr17_+_73750699 | 30.60 |
ENST00000584939.1
|
ITGB4
|
integrin, beta 4 |
| chr11_-_134281812 | 30.16 |
ENST00000392580.1
ENST00000312527.4 |
B3GAT1
|
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
| chr22_+_41956767 | 30.10 |
ENST00000306149.7
|
CSDC2
|
cold shock domain containing C2, RNA binding |
| chr4_-_174320687 | 30.02 |
ENST00000296506.3
|
SCRG1
|
stimulator of chondrogenesis 1 |
| chr19_-_37019562 | 29.69 |
ENST00000523638.1
|
ZNF260
|
zinc finger protein 260 |
| chr3_-_195310802 | 29.57 |
ENST00000421243.1
ENST00000453131.1 |
APOD
|
apolipoprotein D |
| chr7_+_87257854 | 29.29 |
ENST00000394654.3
|
RUNDC3B
|
RUN domain containing 3B |
| chr12_-_16761007 | 28.85 |
ENST00000354662.1
ENST00000441439.2 |
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
| chr14_-_21493649 | 28.77 |
ENST00000553442.1
ENST00000555869.1 ENST00000556457.1 ENST00000397844.2 ENST00000554415.1 |
NDRG2
|
NDRG family member 2 |
| chr16_+_6069586 | 28.64 |
ENST00000547372.1
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
| chr1_-_21978312 | 28.60 |
ENST00000359708.4
ENST00000290101.4 |
RAP1GAP
|
RAP1 GTPase activating protein |
| chr3_-_52479043 | 28.13 |
ENST00000231721.2
ENST00000475739.1 |
SEMA3G
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G |
| chr22_+_39853258 | 27.99 |
ENST00000341184.6
|
MGAT3
|
mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase |
| chr11_-_125366089 | 27.65 |
ENST00000366139.3
ENST00000278919.3 |
FEZ1
|
fasciculation and elongation protein zeta 1 (zygin I) |
| chr19_+_45445491 | 27.48 |
ENST00000592954.1
ENST00000419266.2 ENST00000589057.1 |
APOC4
APOC4-APOC2
|
apolipoprotein C-IV APOC4-APOC2 readthrough (NMD candidate) |
| chr1_+_184356188 | 27.18 |
ENST00000235307.6
|
C1orf21
|
chromosome 1 open reading frame 21 |
| chr19_-_38714847 | 26.85 |
ENST00000420980.2
ENST00000355526.4 |
DPF1
|
D4, zinc and double PHD fingers family 1 |
| chr7_+_121513143 | 26.61 |
ENST00000393386.2
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1 |
| chr7_+_87257701 | 26.55 |
ENST00000338056.3
ENST00000493037.1 |
RUNDC3B
|
RUN domain containing 3B |
| chr12_+_121088291 | 26.36 |
ENST00000351200.2
|
CABP1
|
calcium binding protein 1 |
| chr8_+_10530155 | 25.64 |
ENST00000521818.1
|
C8orf74
|
chromosome 8 open reading frame 74 |
| chr1_+_110453608 | 25.41 |
ENST00000369801.1
|
CSF1
|
colony stimulating factor 1 (macrophage) |
| chr11_+_10472223 | 24.79 |
ENST00000396554.3
ENST00000524866.1 |
AMPD3
|
adenosine monophosphate deaminase 3 |
| chr17_+_1665345 | 24.71 |
ENST00000576406.1
ENST00000571149.1 |
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
| chr8_+_21916710 | 24.67 |
ENST00000523266.1
ENST00000519907.1 |
DMTN
|
dematin actin binding protein |
| chr7_+_95401877 | 24.33 |
ENST00000524053.1
ENST00000324972.6 ENST00000537881.1 ENST00000437599.1 ENST00000359388.4 ENST00000413338.1 |
DYNC1I1
|
dynein, cytoplasmic 1, intermediate chain 1 |
| chr8_+_21916680 | 24.25 |
ENST00000358242.3
ENST00000415253.1 |
DMTN
|
dematin actin binding protein |
| chr15_+_74422585 | 24.23 |
ENST00000561740.1
ENST00000435464.1 ENST00000453268.2 |
ISLR2
|
immunoglobulin superfamily containing leucine-rich repeat 2 |
| chr19_+_30863271 | 24.13 |
ENST00000355537.3
|
ZNF536
|
zinc finger protein 536 |
| chr5_-_42825983 | 24.04 |
ENST00000506577.1
|
SEPP1
|
selenoprotein P, plasma, 1 |
| chr1_+_27561104 | 23.94 |
ENST00000361771.3
|
WDTC1
|
WD and tetratricopeptide repeats 1 |
| chr16_+_5008290 | 23.81 |
ENST00000251170.7
|
SEC14L5
|
SEC14-like 5 (S. cerevisiae) |
| chr7_+_73442422 | 23.79 |
ENST00000358929.4
ENST00000431562.1 ENST00000320492.7 ENST00000438906.1 |
ELN
|
elastin |
| chr2_+_25016282 | 23.42 |
ENST00000260662.1
|
CENPO
|
centromere protein O |
| chr12_+_66218212 | 23.31 |
ENST00000393578.3
ENST00000425208.2 ENST00000536545.1 ENST00000354636.3 |
HMGA2
|
high mobility group AT-hook 2 |
| chr4_+_158141843 | 23.27 |
ENST00000509417.1
ENST00000296526.7 |
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
| chr17_+_17942594 | 23.18 |
ENST00000268719.4
|
GID4
|
GID complex subunit 4 |
| chr7_+_95401851 | 23.08 |
ENST00000447467.2
|
DYNC1I1
|
dynein, cytoplasmic 1, intermediate chain 1 |
| chr3_-_58613323 | 23.00 |
ENST00000474531.1
ENST00000465970.1 |
FAM107A
|
family with sequence similarity 107, member A |
| chr2_-_152955213 | 22.55 |
ENST00000427385.1
|
CACNB4
|
calcium channel, voltage-dependent, beta 4 subunit |
| chr7_+_29519662 | 22.43 |
ENST00000424025.2
ENST00000439711.2 ENST00000421775.2 |
CHN2
|
chimerin 2 |
| chr9_+_103790991 | 22.35 |
ENST00000374874.3
|
LPPR1
|
Lipid phosphate phosphatase-related protein type 1 |
| chr6_+_126070726 | 22.14 |
ENST00000368364.3
|
HEY2
|
hes-related family bHLH transcription factor with YRPW motif 2 |
| chr2_+_25015968 | 22.01 |
ENST00000380834.2
ENST00000473706.1 |
CENPO
|
centromere protein O |
| chr3_-_167813672 | 22.00 |
ENST00000470487.1
|
GOLIM4
|
golgi integral membrane protein 4 |
| chr3_-_127541679 | 21.89 |
ENST00000265052.5
|
MGLL
|
monoglyceride lipase |
| chrX_+_101906294 | 21.89 |
ENST00000361600.5
ENST00000415986.1 ENST00000444152.1 ENST00000537097.1 |
GPRASP1
|
G protein-coupled receptor associated sorting protein 1 |
| chr11_-_89224508 | 21.75 |
ENST00000525196.1
|
NOX4
|
NADPH oxidase 4 |
| chr1_+_110453462 | 21.73 |
ENST00000488198.1
|
CSF1
|
colony stimulating factor 1 (macrophage) |
| chr17_+_8213590 | 21.43 |
ENST00000361926.3
|
ARHGEF15
|
Rho guanine nucleotide exchange factor (GEF) 15 |
| chr12_-_12491608 | 21.36 |
ENST00000545735.1
|
MANSC1
|
MANSC domain containing 1 |
| chr1_+_110453109 | 21.32 |
ENST00000525659.1
|
CSF1
|
colony stimulating factor 1 (macrophage) |
| chr1_-_21671968 | 21.18 |
ENST00000415912.2
|
ECE1
|
endothelin converting enzyme 1 |
| chr1_+_27561007 | 21.05 |
ENST00000319394.3
|
WDTC1
|
WD and tetratricopeptide repeats 1 |
| chr8_-_110620284 | 20.92 |
ENST00000529690.1
|
SYBU
|
syntabulin (syntaxin-interacting) |
| chr19_+_35630628 | 20.82 |
ENST00000588715.1
ENST00000588607.1 |
FXYD1
|
FXYD domain containing ion transport regulator 1 |
| chr20_+_57875658 | 20.66 |
ENST00000371025.3
|
EDN3
|
endothelin 3 |
| chr4_+_158141899 | 20.49 |
ENST00000264426.9
ENST00000506284.1 |
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
| chr11_-_111783595 | 20.47 |
ENST00000528628.1
|
CRYAB
|
crystallin, alpha B |
| chr19_-_47975417 | 20.32 |
ENST00000236877.6
|
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
| chr12_+_57157100 | 20.19 |
ENST00000322165.1
|
HSD17B6
|
hydroxysteroid (17-beta) dehydrogenase 6 |
| chr9_+_87283430 | 20.14 |
ENST00000376214.1
ENST00000376213.1 |
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2 |
| chr19_-_40562063 | 20.14 |
ENST00000598845.1
ENST00000593605.1 ENST00000221355.6 ENST00000434248.1 |
ZNF780B
|
zinc finger protein 780B |
| chr19_-_16582815 | 20.13 |
ENST00000455140.2
ENST00000248070.6 ENST00000594975.1 |
EPS15L1
|
epidermal growth factor receptor pathway substrate 15-like 1 |
| chr22_+_19705928 | 20.05 |
ENST00000383045.3
ENST00000438754.2 |
SEPT5
|
septin 5 |
| chr16_+_58283814 | 20.01 |
ENST00000443128.2
ENST00000219299.4 |
CCDC113
|
coiled-coil domain containing 113 |
| chr8_+_27348626 | 19.94 |
ENST00000517536.1
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic |
| chr19_+_57019212 | 19.68 |
ENST00000308031.5
ENST00000591537.1 |
ZNF471
|
zinc finger protein 471 |
| chr11_-_107582775 | 19.62 |
ENST00000305991.2
|
SLN
|
sarcolipin |
| chr17_+_64961026 | 19.61 |
ENST00000262138.3
|
CACNG4
|
calcium channel, voltage-dependent, gamma subunit 4 |
| chr14_-_64970494 | 19.60 |
ENST00000608382.1
|
ZBTB25
|
zinc finger and BTB domain containing 25 |
| chr14_+_96505659 | 19.48 |
ENST00000555004.1
|
C14orf132
|
chromosome 14 open reading frame 132 |
| chr8_+_144816303 | 19.41 |
ENST00000533004.1
|
FAM83H-AS1
|
FAM83H antisense RNA 1 (head to head) |
| chr10_-_62332357 | 19.21 |
ENST00000503366.1
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G) |
| chr16_-_20681177 | 19.04 |
ENST00000524149.1
|
ACSM1
|
acyl-CoA synthetase medium-chain family member 1 |
| chr3_-_9291063 | 19.03 |
ENST00000383836.3
|
SRGAP3
|
SLIT-ROBO Rho GTPase activating protein 3 |
| chr19_-_56988677 | 19.00 |
ENST00000504904.3
ENST00000292069.6 |
ZNF667
|
zinc finger protein 667 |
| chr17_+_43972010 | 18.98 |
ENST00000334239.8
ENST00000446361.3 |
MAPT
|
microtubule-associated protein tau |
| chr17_-_10017864 | 18.79 |
ENST00000323816.4
|
GAS7
|
growth arrest-specific 7 |
| chr3_-_127542051 | 18.78 |
ENST00000398104.1
|
MGLL
|
monoglyceride lipase |
| chr20_+_57875758 | 18.43 |
ENST00000395654.3
|
EDN3
|
endothelin 3 |
| chr19_+_45445524 | 18.20 |
ENST00000591600.1
|
APOC4
|
apolipoprotein C-IV |
| chr12_-_6798616 | 18.13 |
ENST00000355772.4
ENST00000417772.3 ENST00000396801.3 ENST00000396799.2 |
ZNF384
|
zinc finger protein 384 |
| chr20_+_17207665 | 18.01 |
ENST00000536609.1
|
PCSK2
|
proprotein convertase subtilisin/kexin type 2 |
| chr22_-_19512893 | 18.00 |
ENST00000403084.1
ENST00000413119.2 |
CLDN5
|
claudin 5 |
| chr16_+_72090053 | 17.90 |
ENST00000576168.2
ENST00000567185.3 ENST00000567612.2 |
HP
|
haptoglobin |
| chr13_-_37494365 | 17.88 |
ENST00000350148.5
|
SMAD9
|
SMAD family member 9 |
| chr4_-_186732048 | 17.86 |
ENST00000448662.2
ENST00000439049.1 ENST00000420158.1 ENST00000431808.1 ENST00000319471.9 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr18_+_6729725 | 17.71 |
ENST00000400091.2
ENST00000583410.1 ENST00000584387.1 |
ARHGAP28
|
Rho GTPase activating protein 28 |
| chr19_+_41509851 | 17.70 |
ENST00000593831.1
ENST00000330446.5 |
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6 |
| chr20_+_17207636 | 17.63 |
ENST00000262545.2
|
PCSK2
|
proprotein convertase subtilisin/kexin type 2 |
| chr3_-_127542021 | 17.62 |
ENST00000434178.2
|
MGLL
|
monoglyceride lipase |
| chr14_-_21493884 | 17.42 |
ENST00000556974.1
ENST00000554419.1 ENST00000298687.5 ENST00000397858.1 ENST00000360463.3 ENST00000350792.3 ENST00000397847.2 |
NDRG2
|
NDRG family member 2 |
| chr1_-_177133818 | 17.36 |
ENST00000424564.2
ENST00000361833.2 |
ASTN1
|
astrotactin 1 |
| chr19_-_14887568 | 17.29 |
ENST00000596991.2
ENST00000594294.1 ENST00000594076.1 ENST00000595839.1 ENST00000392965.3 ENST00000601345.1 |
EMR2
|
egf-like module containing, mucin-like, hormone receptor-like 2 |
| chr14_+_71108460 | 17.12 |
ENST00000256367.2
|
TTC9
|
tetratricopeptide repeat domain 9 |
| chr6_-_11807277 | 17.08 |
ENST00000379415.2
|
ADTRP
|
androgen-dependent TFPI-regulating protein |
| chr11_-_89224638 | 17.06 |
ENST00000535633.1
ENST00000263317.4 |
NOX4
|
NADPH oxidase 4 |
| chr21_-_31312230 | 17.05 |
ENST00000399907.1
ENST00000399909.1 |
GRIK1
|
glutamate receptor, ionotropic, kainate 1 |
| chr2_-_223163465 | 17.00 |
ENST00000409828.3
ENST00000350526.4 ENST00000258387.5 ENST00000409551.3 ENST00000392069.2 ENST00000344493.4 ENST00000336840.6 ENST00000392070.2 |
PAX3
|
paired box 3 |
| chr1_+_46668994 | 16.84 |
ENST00000371980.3
|
LURAP1
|
leucine rich adaptor protein 1 |
| chr12_+_50451462 | 16.83 |
ENST00000447966.2
|
ASIC1
|
acid-sensing (proton-gated) ion channel 1 |
| chrX_+_135229559 | 16.76 |
ENST00000394155.2
|
FHL1
|
four and a half LIM domains 1 |
| chr1_+_160765947 | 16.73 |
ENST00000263285.6
ENST00000368039.2 |
LY9
|
lymphocyte antigen 9 |
| chr21_-_31311818 | 16.71 |
ENST00000535441.1
ENST00000309434.7 ENST00000327783.4 ENST00000389124.2 ENST00000389125.3 ENST00000399913.1 |
GRIK1
|
glutamate receptor, ionotropic, kainate 1 |
| chr19_-_36297348 | 16.45 |
ENST00000589835.1
|
PRODH2
|
proline dehydrogenase (oxidase) 2 |
| chr4_-_57547870 | 16.41 |
ENST00000381260.3
ENST00000420433.1 ENST00000554144.1 ENST00000557328.1 |
HOPX
|
HOP homeobox |
| chr7_+_29519486 | 16.27 |
ENST00000409041.4
|
CHN2
|
chimerin 2 |
| chr17_-_48207157 | 16.24 |
ENST00000330175.4
ENST00000503131.1 |
SAMD14
|
sterile alpha motif domain containing 14 |
| chr20_+_30946106 | 16.23 |
ENST00000375687.4
ENST00000542461.1 |
ASXL1
|
additional sex combs like 1 (Drosophila) |
| chr17_-_56406117 | 16.23 |
ENST00000268893.6
ENST00000355701.3 |
BZRAP1
|
benzodiazepine receptor (peripheral) associated protein 1 |
| chr2_+_238475217 | 16.19 |
ENST00000165524.1
|
PRLH
|
prolactin releasing hormone |
| chr7_+_73442102 | 16.19 |
ENST00000445912.1
ENST00000252034.7 |
ELN
|
elastin |
| chr16_+_1578674 | 15.98 |
ENST00000253934.5
|
TMEM204
|
transmembrane protein 204 |
| chr4_+_158142750 | 15.94 |
ENST00000505888.1
ENST00000449365.1 |
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
| chr19_+_54024251 | 15.75 |
ENST00000253144.9
|
ZNF331
|
zinc finger protein 331 |
| chr16_-_21289627 | 15.74 |
ENST00000396023.2
ENST00000415987.2 |
CRYM
|
crystallin, mu |
| chr6_-_84419101 | 15.60 |
ENST00000520302.1
ENST00000520213.1 ENST00000439399.2 ENST00000428679.2 ENST00000437520.1 |
SNAP91
|
synaptosomal-associated protein, 91kDa |
| chr13_-_37494391 | 15.59 |
ENST00000379826.4
|
SMAD9
|
SMAD family member 9 |
| chr6_+_36210980 | 15.55 |
ENST00000312917.5
ENST00000388715.3 |
PNPLA1
|
patatin-like phospholipase domain containing 1 |
| chr19_-_36980337 | 15.54 |
ENST00000434377.2
ENST00000424129.2 ENST00000452939.1 ENST00000427002.1 |
ZNF566
|
zinc finger protein 566 |
| chr4_+_62067860 | 15.48 |
ENST00000514591.1
|
LPHN3
|
latrophilin 3 |
| chr7_+_73442457 | 15.46 |
ENST00000438880.1
ENST00000414324.1 ENST00000380562.4 |
ELN
|
elastin |
| chr12_+_7023491 | 15.26 |
ENST00000541477.1
ENST00000229277.1 |
ENO2
|
enolase 2 (gamma, neuronal) |
| chr19_-_36980455 | 15.24 |
ENST00000454319.1
ENST00000392170.2 |
ZNF566
|
zinc finger protein 566 |
| chr7_+_86273952 | 15.14 |
ENST00000536043.1
|
GRM3
|
glutamate receptor, metabotropic 3 |
| chr19_+_46171464 | 15.02 |
ENST00000590918.1
ENST00000263281.3 ENST00000304207.8 |
GIPR
|
gastric inhibitory polypeptide receptor |
| chr7_-_50518022 | 14.85 |
ENST00000356889.4
ENST00000420829.1 ENST00000448788.1 ENST00000395556.2 ENST00000422854.1 ENST00000435566.1 ENST00000433017.1 |
FIGNL1
|
fidgetin-like 1 |
| chr10_-_30348439 | 14.77 |
ENST00000375377.1
|
KIAA1462
|
KIAA1462 |
| chr5_-_142000883 | 14.75 |
ENST00000359370.6
|
FGF1
|
fibroblast growth factor 1 (acidic) |
| chr5_-_148033726 | 14.64 |
ENST00000354217.2
ENST00000314512.6 ENST00000362016.2 |
HTR4
|
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled |
| chr3_+_186435065 | 14.63 |
ENST00000287611.2
ENST00000265023.4 |
KNG1
|
kininogen 1 |
| chr15_+_84116106 | 14.53 |
ENST00000535412.1
ENST00000324537.5 |
SH3GL3
|
SH3-domain GRB2-like 3 |
| chr17_+_1665253 | 14.45 |
ENST00000254722.4
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
| chr7_+_73442487 | 14.36 |
ENST00000380575.4
ENST00000380584.4 ENST00000458204.1 ENST00000357036.5 ENST00000417091.1 ENST00000429192.1 ENST00000442310.1 ENST00000380553.4 ENST00000380576.5 ENST00000428787.1 ENST00000320399.6 |
ELN
|
elastin |
| chr4_-_8873531 | 14.35 |
ENST00000400677.3
|
HMX1
|
H6 family homeobox 1 |
| chr6_-_31620403 | 14.25 |
ENST00000451898.1
ENST00000439687.2 ENST00000362049.6 ENST00000424480.1 |
BAG6
|
BCL2-associated athanogene 6 |
| chr6_-_31514516 | 14.25 |
ENST00000303892.5
ENST00000483251.1 |
ATP6V1G2
|
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 |
| chr10_-_135150367 | 14.22 |
ENST00000368555.3
ENST00000252939.4 ENST00000368558.1 ENST00000368556.2 |
CALY
|
calcyon neuron-specific vesicular protein |
| chr1_+_160765884 | 14.21 |
ENST00000392203.4
|
LY9
|
lymphocyte antigen 9 |
| chr7_-_44365020 | 14.19 |
ENST00000395747.2
ENST00000347193.4 ENST00000346990.4 ENST00000258682.6 ENST00000353625.4 ENST00000421607.1 ENST00000424197.1 ENST00000502837.2 ENST00000350811.3 ENST00000395749.2 |
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta |
| chr19_+_35630344 | 14.15 |
ENST00000455515.2
|
FXYD1
|
FXYD domain containing ion transport regulator 1 |
| chr12_+_79258444 | 14.09 |
ENST00000261205.4
|
SYT1
|
synaptotagmin I |
| chr8_+_79428539 | 13.98 |
ENST00000352966.5
|
PKIA
|
protein kinase (cAMP-dependent, catalytic) inhibitor alpha |
| chr8_-_38239732 | 13.91 |
ENST00000534155.1
ENST00000433384.2 ENST00000317025.8 ENST00000316985.3 |
WHSC1L1
|
Wolf-Hirschhorn syndrome candidate 1-like 1 |
| chr18_+_74534479 | 13.83 |
ENST00000320610.9
|
ZNF236
|
zinc finger protein 236 |
| chr11_-_32457176 | 13.68 |
ENST00000332351.3
|
WT1
|
Wilms tumor 1 |
| chr1_+_110453514 | 13.67 |
ENST00000369802.3
ENST00000420111.2 |
CSF1
|
colony stimulating factor 1 (macrophage) |
| chr5_-_11588907 | 13.65 |
ENST00000513598.1
ENST00000503622.1 |
CTNND2
|
catenin (cadherin-associated protein), delta 2 |
| chrX_+_135229600 | 13.64 |
ENST00000370690.3
|
FHL1
|
four and a half LIM domains 1 |
| chr9_+_129089088 | 13.62 |
ENST00000361171.3
ENST00000545391.1 |
MVB12B
|
multivesicular body subunit 12B |
| chr8_-_102803163 | 13.60 |
ENST00000523645.1
ENST00000520346.1 ENST00000220931.6 ENST00000522448.1 ENST00000522951.1 ENST00000522252.1 ENST00000519098.1 |
NCALD
|
neurocalcin delta |
| chr11_+_6280927 | 13.57 |
ENST00000334619.2
|
CCKBR
|
cholecystokinin B receptor |
| chr11_-_70507867 | 13.55 |
ENST00000412252.1
ENST00000409161.1 ENST00000409530.1 |
SHANK2
|
SH3 and multiple ankyrin repeat domains 2 |
| chr20_-_50385138 | 13.53 |
ENST00000338821.5
|
ATP9A
|
ATPase, class II, type 9A |
| chr12_+_133758115 | 13.51 |
ENST00000541009.2
ENST00000592241.1 |
ZNF268
|
zinc finger protein 268 |
| chr1_+_50575292 | 13.51 |
ENST00000371821.1
ENST00000371819.1 |
ELAVL4
|
ELAV like neuron-specific RNA binding protein 4 |
| chr16_+_6069664 | 13.51 |
ENST00000422070.4
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
| chr11_-_115630900 | 13.48 |
ENST00000537070.1
ENST00000499809.1 ENST00000514294.2 ENST00000535683.1 |
LINC00900
|
long intergenic non-protein coding RNA 900 |
| chr17_+_17942684 | 13.43 |
ENST00000376345.3
|
GID4
|
GID complex subunit 4 |
| chr12_+_79258547 | 13.37 |
ENST00000457153.2
|
SYT1
|
synaptotagmin I |
| chr12_+_5541267 | 13.35 |
ENST00000423158.3
|
NTF3
|
neurotrophin 3 |
| chr18_+_77439775 | 13.20 |
ENST00000299543.7
ENST00000075430.7 |
CTDP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1 |
| chr11_+_17756279 | 13.17 |
ENST00000265969.6
|
KCNC1
|
potassium voltage-gated channel, Shaw-related subfamily, member 1 |
| chr7_+_86274145 | 13.16 |
ENST00000439827.1
ENST00000394720.2 ENST00000421579.1 |
GRM3
|
glutamate receptor, metabotropic 3 |
| chr12_-_6798523 | 13.13 |
ENST00000319770.3
|
ZNF384
|
zinc finger protein 384 |
| chr7_-_38389573 | 13.08 |
ENST00000390344.2
|
TRGV5
|
T cell receptor gamma variable 5 |
| chr18_+_29171689 | 12.97 |
ENST00000237014.3
|
TTR
|
transthyretin |
| chr2_-_37193606 | 12.89 |
ENST00000379213.2
ENST00000263918.4 |
STRN
|
striatin, calmodulin binding protein |
| chr12_-_6798410 | 12.89 |
ENST00000361959.3
ENST00000436774.2 ENST00000544482.1 |
ZNF384
|
zinc finger protein 384 |
| chr9_-_72287191 | 12.79 |
ENST00000265381.4
|
APBA1
|
amyloid beta (A4) precursor protein-binding, family A, member 1 |
| chr17_-_37309480 | 12.76 |
ENST00000539608.1
|
PLXDC1
|
plexin domain containing 1 |
| chr1_+_77747656 | 12.71 |
ENST00000354567.2
|
AK5
|
adenylate kinase 5 |
| chr1_-_149889382 | 12.65 |
ENST00000369145.1
ENST00000369146.3 |
SV2A
|
synaptic vesicle glycoprotein 2A |
| chr19_-_43709703 | 12.61 |
ENST00000599391.1
ENST00000244295.9 |
PSG4
|
pregnancy specific beta-1-glycoprotein 4 |
| chr14_-_54420133 | 12.58 |
ENST00000559501.1
ENST00000558984.1 |
BMP4
|
bone morphogenetic protein 4 |
| chr15_+_84115868 | 12.58 |
ENST00000427482.2
|
SH3GL3
|
SH3-domain GRB2-like 3 |
| chr11_-_32457075 | 12.57 |
ENST00000448076.3
|
WT1
|
Wilms tumor 1 |
| chr1_+_228353495 | 12.55 |
ENST00000366711.3
|
IBA57
|
IBA57, iron-sulfur cluster assembly homolog (S. cerevisiae) |
| chr11_+_66278080 | 12.47 |
ENST00000318312.7
ENST00000526815.1 ENST00000537537.1 ENST00000525809.1 ENST00000455748.2 ENST00000393994.2 |
BBS1
|
Bardet-Biedl syndrome 1 |
| chr3_+_185080908 | 12.40 |
ENST00000265026.3
|
MAP3K13
|
mitogen-activated protein kinase kinase kinase 13 |
Network of associatons between targets according to the STRING database.
First level regulatory network of EPAS1_BCL3
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 32.4 | 194.7 | GO:0010734 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 23.7 | 71.1 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 18.8 | 94.1 | GO:0060611 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 15.5 | 92.9 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 14.8 | 74.1 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
| 12.6 | 37.9 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 12.1 | 36.4 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 11.4 | 57.1 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 10.8 | 32.3 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 9.9 | 29.8 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 9.8 | 39.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 9.2 | 27.5 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 9.1 | 27.3 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 8.3 | 25.0 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 8.3 | 58.3 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 8.1 | 16.2 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 7.8 | 39.2 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 7.8 | 23.3 | GO:0019605 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
| 7.6 | 30.3 | GO:0072299 | posterior mesonephric tubule development(GO:0072166) negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
| 7.4 | 22.1 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
| 7.1 | 35.6 | GO:0030070 | insulin processing(GO:0030070) |
| 7.0 | 20.9 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 6.7 | 20.2 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 6.5 | 45.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 6.4 | 19.3 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 6.2 | 18.6 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
| 6.1 | 36.6 | GO:0061518 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 6.0 | 17.9 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 5.7 | 17.1 | GO:0048691 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 5.4 | 10.9 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
| 5.3 | 21.3 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 5.3 | 21.2 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 5.3 | 5.3 | GO:0099545 | trans-synaptic signaling by trans-synaptic complex(GO:0099545) |
| 5.2 | 36.3 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
| 5.0 | 20.2 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 4.9 | 29.5 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 4.8 | 28.9 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 4.8 | 19.2 | GO:1900827 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 4.7 | 19.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 4.7 | 14.1 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 4.6 | 18.5 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
| 4.6 | 23.0 | GO:0099538 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 4.6 | 27.7 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 4.5 | 13.5 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 4.4 | 13.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 4.3 | 47.4 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 4.2 | 12.7 | GO:0006172 | ADP biosynthetic process(GO:0006172) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 4.1 | 4.1 | GO:0045807 | positive regulation of endocytosis(GO:0045807) |
| 4.0 | 12.0 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 3.9 | 7.8 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
| 3.8 | 11.5 | GO:0042938 | dipeptide transport(GO:0042938) |
| 3.7 | 11.1 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 3.6 | 7.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 3.5 | 17.3 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 3.5 | 13.8 | GO:0001678 | cellular glucose homeostasis(GO:0001678) |
| 3.4 | 37.1 | GO:0090232 | peripheral nervous system myelin maintenance(GO:0032287) positive regulation of spindle checkpoint(GO:0090232) |
| 3.3 | 16.7 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 3.3 | 26.6 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 3.2 | 9.5 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 3.1 | 6.3 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 3.1 | 49.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 3.1 | 6.2 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 3.0 | 6.1 | GO:0061010 | gall bladder development(GO:0061010) |
| 3.0 | 57.6 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
| 3.0 | 8.9 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 3.0 | 8.9 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 3.0 | 11.8 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 2.9 | 139.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 2.9 | 8.7 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
| 2.8 | 11.4 | GO:1990936 | metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
| 2.8 | 8.5 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 2.8 | 5.7 | GO:2000364 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
| 2.8 | 8.4 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 2.8 | 8.3 | GO:0008078 | mesoderm migration involved in gastrulation(GO:0007509) mesodermal cell migration(GO:0008078) |
| 2.8 | 5.5 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
| 2.7 | 16.5 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 2.7 | 27.4 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 2.7 | 8.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) establishment of meiotic spindle localization(GO:0051295) |
| 2.7 | 21.4 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 2.6 | 13.2 | GO:0021759 | globus pallidus development(GO:0021759) |
| 2.6 | 18.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 2.6 | 36.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 2.6 | 12.8 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 2.5 | 7.5 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 2.5 | 50.0 | GO:0090128 | regulation of synapse maturation(GO:0090128) |
| 2.5 | 27.4 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 2.5 | 7.4 | GO:1902722 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) positive regulation of prolactin secretion(GO:1902722) |
| 2.4 | 7.2 | GO:2001301 | cellular response to interleukin-13(GO:0035963) lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 2.3 | 2.3 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) negative regulation of gonadotropin secretion(GO:0032277) positive regulation of gonadotropin secretion(GO:0032278) interferon-gamma biosynthetic process(GO:0042095) regulation of interferon-gamma biosynthetic process(GO:0045072) negative regulation of interferon-gamma biosynthetic process(GO:0045077) negative regulation of B cell differentiation(GO:0045578) negative regulation of macrophage differentiation(GO:0045650) regulation of follicle-stimulating hormone secretion(GO:0046880) positive regulation of follicle-stimulating hormone secretion(GO:0046881) negative regulation of follicle-stimulating hormone secretion(GO:0046882) follicle-stimulating hormone secretion(GO:0046884) |
| 2.3 | 7.0 | GO:0003099 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 2.3 | 32.5 | GO:0035878 | nail development(GO:0035878) |
| 2.3 | 18.0 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 2.2 | 6.7 | GO:1904300 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 2.2 | 20.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 2.2 | 6.6 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 2.2 | 28.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 2.2 | 13.1 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
| 2.2 | 10.8 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) minus-end-directed organelle transport along microtubule(GO:0072385) |
| 2.1 | 6.4 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
| 2.1 | 23.3 | GO:0015886 | heme transport(GO:0015886) |
| 2.1 | 6.3 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 2.0 | 6.1 | GO:0046440 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 2.0 | 6.0 | GO:0031049 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
| 2.0 | 7.9 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 2.0 | 17.6 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 1.9 | 5.8 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 1.9 | 7.6 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 1.9 | 5.7 | GO:0060164 | amygdala development(GO:0021764) regulation of timing of neuron differentiation(GO:0060164) |
| 1.9 | 7.6 | GO:1905229 | cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 1.9 | 41.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 1.9 | 5.6 | GO:0033341 | regulation of collagen binding(GO:0033341) |
| 1.9 | 18.8 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 1.8 | 20.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.8 | 7.3 | GO:0021997 | response to chlorate(GO:0010157) neural plate axis specification(GO:0021997) |
| 1.8 | 21.6 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 1.8 | 5.4 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 1.8 | 5.3 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
| 1.7 | 34.7 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
| 1.7 | 3.4 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 1.7 | 6.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 1.7 | 8.4 | GO:0080009 | mRNA methylation(GO:0080009) |
| 1.7 | 6.7 | GO:0061196 | fungiform papilla development(GO:0061196) |
| 1.6 | 8.1 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 1.6 | 3.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 1.6 | 21.9 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 1.6 | 1.6 | GO:0072197 | ureter urothelium development(GO:0072190) ureter morphogenesis(GO:0072197) |
| 1.6 | 7.8 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 1.5 | 10.6 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 1.5 | 4.5 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 1.5 | 7.4 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 1.5 | 45.4 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 1.5 | 21.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 1.4 | 18.7 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
| 1.4 | 8.5 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 1.4 | 5.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 1.4 | 14.9 | GO:0071625 | vocalization behavior(GO:0071625) |
| 1.3 | 44.1 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
| 1.3 | 3.8 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 1.2 | 16.2 | GO:0002021 | response to dietary excess(GO:0002021) |
| 1.2 | 5.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 1.2 | 7.4 | GO:0048263 | determination of dorsal identity(GO:0048263) |
| 1.2 | 9.8 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
| 1.2 | 13.5 | GO:0000050 | urea cycle(GO:0000050) |
| 1.2 | 7.2 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 1.2 | 4.8 | GO:0003335 | corneocyte development(GO:0003335) |
| 1.2 | 15.4 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 1.2 | 3.5 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 1.2 | 5.8 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
| 1.2 | 25.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 1.1 | 20.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 1.1 | 17.0 | GO:0014029 | neural crest formation(GO:0014029) |
| 1.1 | 2.2 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 1.1 | 4.4 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
| 1.1 | 18.4 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
| 1.1 | 5.4 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 1.1 | 4.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 1.1 | 5.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 1.1 | 7.4 | GO:0042428 | serotonin metabolic process(GO:0042428) |
| 1.0 | 5.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 1.0 | 25.9 | GO:0032098 | regulation of appetite(GO:0032098) |
| 1.0 | 58.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 1.0 | 21.5 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 1.0 | 10.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 1.0 | 36.1 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
| 1.0 | 9.0 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 1.0 | 2.0 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 1.0 | 6.0 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
| 1.0 | 7.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 1.0 | 4.0 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 1.0 | 10.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 1.0 | 2.0 | GO:1904954 | Spemann organizer formation(GO:0060061) canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
| 1.0 | 6.8 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
| 1.0 | 4.9 | GO:0042420 | dopamine catabolic process(GO:0042420) |
| 1.0 | 4.8 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 1.0 | 56.8 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
| 1.0 | 27.9 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 1.0 | 13.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 1.0 | 9.5 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
| 0.9 | 10.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.9 | 15.9 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.9 | 3.7 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.9 | 3.7 | GO:0061056 | sclerotome development(GO:0061056) |
| 0.9 | 10.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.9 | 2.8 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.9 | 5.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.9 | 69.2 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
| 0.9 | 6.4 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.9 | 12.8 | GO:0021510 | spinal cord development(GO:0021510) |
| 0.9 | 13.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.9 | 6.3 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.9 | 24.2 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.9 | 2.7 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 0.9 | 10.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.9 | 9.7 | GO:0060004 | reflex(GO:0060004) |
| 0.9 | 26.5 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.9 | 2.6 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 0.9 | 4.3 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.9 | 12.9 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.9 | 6.9 | GO:0035107 | appendage morphogenesis(GO:0035107) limb morphogenesis(GO:0035108) |
| 0.9 | 2.6 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
| 0.9 | 23.9 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.8 | 4.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
| 0.8 | 11.8 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.8 | 16.0 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.8 | 28.6 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.8 | 2.5 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.8 | 7.5 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.8 | 5.0 | GO:0051480 | regulation of cytosolic calcium ion concentration(GO:0051480) |
| 0.8 | 27.4 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
| 0.8 | 3.3 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.8 | 5.0 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.8 | 5.7 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
| 0.8 | 49.8 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
| 0.8 | 8.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.8 | 6.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.8 | 7.2 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.8 | 2.4 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.8 | 7.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.8 | 15.7 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.8 | 3.9 | GO:0021861 | forebrain radial glial cell differentiation(GO:0021861) odontoblast differentiation(GO:0071895) |
| 0.8 | 3.1 | GO:0071321 | positive regulation of oocyte development(GO:0060282) cellular response to cGMP(GO:0071321) |
| 0.8 | 7.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.8 | 5.4 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) parathyroid gland development(GO:0060017) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.8 | 22.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.8 | 4.5 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.7 | 16.9 | GO:0006067 | ethanol metabolic process(GO:0006067) |
| 0.7 | 2.9 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 0.7 | 4.3 | GO:0048511 | rhythmic process(GO:0048511) |
| 0.7 | 32.2 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.7 | 10.3 | GO:0007625 | grooming behavior(GO:0007625) |
| 0.7 | 15.8 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
| 0.7 | 14.9 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.7 | 2.7 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
| 0.7 | 11.4 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.7 | 28.8 | GO:0097178 | ruffle assembly(GO:0097178) |
| 0.7 | 4.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
| 0.7 | 32.0 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.7 | 3.9 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.7 | 4.6 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.6 | 13.5 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.6 | 8.9 | GO:0032094 | response to food(GO:0032094) |
| 0.6 | 7.6 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.6 | 1.8 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
| 0.6 | 16.4 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
| 0.6 | 4.8 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.6 | 16.3 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.6 | 4.8 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.6 | 3.6 | GO:0008544 | epidermis development(GO:0008544) |
| 0.6 | 6.5 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
| 0.6 | 2.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.6 | 2.9 | GO:0001766 | membrane raft polarization(GO:0001766) regulation of myeloid dendritic cell activation(GO:0030885) membrane raft distribution(GO:0031580) |
| 0.6 | 5.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.6 | 9.1 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.6 | 7.9 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.6 | 5.0 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
| 0.6 | 5.0 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.6 | 6.7 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.6 | 1.7 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.5 | 14.2 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.5 | 4.9 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.5 | 18.1 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.5 | 7.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.5 | 3.7 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.5 | 14.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.5 | 3.2 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.5 | 15.2 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.5 | 18.9 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
| 0.5 | 14.6 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.5 | 5.2 | GO:0032962 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.5 | 4.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.5 | 2.1 | GO:0006568 | tryptophan metabolic process(GO:0006568) |
| 0.5 | 18.9 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.5 | 31.2 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
| 0.5 | 6.1 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.5 | 5.0 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.5 | 7.5 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
| 0.5 | 6.5 | GO:0010039 | response to iron ion(GO:0010039) |
| 0.5 | 12.5 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
| 0.5 | 5.5 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
| 0.5 | 2.9 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.5 | 7.4 | GO:0007049 | cell cycle(GO:0007049) |
| 0.5 | 1.0 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 0.5 | 3.4 | GO:0007379 | segment specification(GO:0007379) |
| 0.5 | 12.0 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.5 | 2.9 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.5 | 23.4 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
| 0.5 | 4.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.5 | 1.9 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.5 | 1.4 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.5 | 18.9 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.5 | 1.4 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.5 | 6.6 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.5 | 2.3 | GO:0009624 | response to nematode(GO:0009624) |
| 0.4 | 10.1 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.4 | 2.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.4 | 11.1 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.4 | 3.8 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.4 | 8.9 | GO:0008038 | neuron recognition(GO:0008038) |
| 0.4 | 1.6 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) post-embryonic organ morphogenesis(GO:0048563) |
| 0.4 | 2.8 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.4 | 1.6 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
| 0.4 | 2.8 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.4 | 7.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.4 | 13.6 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
| 0.4 | 5.5 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.4 | 7.7 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
| 0.3 | 0.7 | GO:0033686 | regulation of luteinizing hormone secretion(GO:0033684) positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.3 | 4.8 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.3 | 4.7 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
| 0.3 | 8.2 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
| 0.3 | 7.1 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 0.3 | 1.3 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.3 | 1.6 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.3 | 8.6 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.3 | 1.6 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.3 | 12.2 | GO:0007631 | feeding behavior(GO:0007631) |
| 0.3 | 2.5 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.3 | 5.3 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
| 0.3 | 0.9 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.3 | 13.3 | GO:0006942 | regulation of striated muscle contraction(GO:0006942) |
| 0.3 | 5.3 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.3 | 2.5 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
| 0.3 | 6.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.3 | 4.1 | GO:0032196 | transposition(GO:0032196) |
| 0.3 | 2.3 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.3 | 6.6 | GO:0001525 | angiogenesis(GO:0001525) |
| 0.3 | 12.6 | GO:0030279 | negative regulation of ossification(GO:0030279) |
| 0.3 | 7.2 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
| 0.3 | 2.5 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.3 | 5.8 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
| 0.3 | 1.6 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.3 | 3.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.3 | 6.7 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.3 | 4.3 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
| 0.3 | 7.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.3 | 2.6 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
| 0.3 | 8.3 | GO:0006954 | inflammatory response(GO:0006954) |
| 0.3 | 13.6 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
| 0.3 | 8.4 | GO:0051260 | protein homooligomerization(GO:0051260) |
| 0.3 | 3.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.3 | 1.8 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.3 | 0.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.2 | 4.7 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
| 0.2 | 6.0 | GO:0050779 | RNA destabilization(GO:0050779) |
| 0.2 | 2.9 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.2 | 5.5 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
| 0.2 | 3.8 |